Our data suggest that certain germline variants in ANGPT2/TEK and VEGF/VEGFR2 axes may have predictive and prognostic potential in HNSCC treated with radiation or chemoradiation. The gene discussed is ANGPT2; the disease is head and neck squamous cell carcinoma.